These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18287271)

  • 21. Magnetic resonance imaging-guided attenuation and scatter corrections in three-dimensional brain positron emission tomography.
    Zaidi H; Montandon ML; Slosman DO
    Med Phys; 2003 May; 30(5):937-48. PubMed ID: 12773003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroimaging of epilepsy.
    Maehara T
    Neuropathology; 2007 Dec; 27(6):585-93. PubMed ID: 18021381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central-type benzodiazepine receptors and epileptogenesis: basic mechanisms and clinical validity.
    Morimoto K; Tamagami H; Matsuda K
    Epilepsia; 2005; 46 Suppl 5():184-8. PubMed ID: 15987275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fukuchi K; Hori M; Nishimura T
    J Nucl Med; 1998 Aug; 39(8):1348-53. PubMed ID: 9708504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of cerebral function using iomazenil SPECT for patients with traumatic brain injury.
    Shibata Y; Endo K
    Acta Neurochir Suppl; 2013; 118():255-8. PubMed ID: 23564143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of 123I-iomazenil SPECT in patients with ischemic cerebrovascular disease: comparative study with 123I-IMP SPECT].
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fujita M; Fukuchi K; Watanabe Y; Terakawa H; Uehara T; Nishimura T
    Kaku Igaku; 1996 Jun; 33(6):587-97. PubMed ID: 8741503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children.
    Véra P; Kaminska A; Cieuta C; Hollo A; Stiévenart JL; Gardin I; Ville D; Mangin JF; Plouin P; Dulac O; Chiron C
    J Nucl Med; 1999 May; 40(5):786-92. PubMed ID: 10319751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of concomitant clobazam on interictal 123I-iomazenil SPECT.
    Duncan S; Gillen GJ; Brodie MJ
    Epilepsy Res; 1993 May; 15(1):61-6. PubMed ID: 8325279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas.
    Saur D; Buchert R; Knab R; Weiller C; Röther J
    Stroke; 2006 Nov; 37(11):2713-9. PubMed ID: 17023671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced GABAA receptor density contralateral to a potentially epileptogenic MRI abnormality in a patient with complex partial seizures.
    Kuwert T; Stodieck SR; Puskás C; Diehl B; Puskaś Z; Schuierer G; Vollet B; Schober O
    Eur J Nucl Med; 1996 Jan; 23(1):95-8. PubMed ID: 8586109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of methods to detect interhemispheric asymmetry on cerebral perfusion SPECT: application to epilepsy.
    Aubert-Broche B; Jannin P; Biraben A; Bernard AM; Haegelen C; Le Jeune FP; Gibaud B
    J Nucl Med; 2005 Apr; 46(4):707-13. PubMed ID: 15809495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved volumetric measurement of brain structure with a distortion correction procedure using an ADNI phantom.
    Maikusa N; Yamashita F; Tanaka K; Abe O; Kawaguchi A; Kabasawa H; Chiba S; Kasahara A; Kobayashi N; Yuasa T; Sato N; Matsuda H; Iwatsubo T;
    Med Phys; 2013 Jun; 40(6):062303. PubMed ID: 23718605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the side of epileptic focus with 123I-Iomazenil SPECT. A comparison with 18FDG-PET and ictal EEG findings in patients with medically intractable complex partial seizures.
    van Huffelen AC; van Isselt JW; van Veelen CW; van Rijk PP; van Bentum AM; Dive D; Maquet P; Franck G; Velis DN; van Emde Boas W
    Acta Neurochir Suppl (Wien); 1990; 50():95-9. PubMed ID: 1965875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [11C]Flumazenil PET in patients with epilepsy with dual pathology.
    Juhász C; Nagy F; Muzik O; Watson C; Shah J; Chugani HT
    Epilepsia; 1999 May; 40(5):566-74. PubMed ID: 10386525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation correction of somatostatin receptor SPECT by integrated low-dose CT: is there an impact on sensitivity?
    Steffen IG; Mehl S; Heuck F; Elgeti F; Furth C; Amthauer H; Ruf J
    Clin Nucl Med; 2009 Dec; 34(12):869-73. PubMed ID: 20139819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT].
    Kawabata K; Tachibana H; Sugita M; Fukuchi M
    Kaku Igaku; 1996 Apr; 33(4):391-7. PubMed ID: 8683878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The usefulness of repeated ictal SPET for the localization of epileptogenic zones in intractable epilepsy.
    Lee DS; Lee SK; Kim YK; Kang E; Lee JS; Chung JK; Lee MC
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):607-14. PubMed ID: 11976798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. I-123 iomazenil SPECT in patients with mental disorders.
    Nakabeppu Y; Nakajo M; Naruo T; Obo Y; Nozoe S; Takigawa M; Tsuchimochi S; Tani A; Tanaka H
    Ann Nucl Med; 1997 Nov; 11(4):339-44. PubMed ID: 9460528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.